Illumina files for patent infringement over prenatal test
08-09-2017
NataliaDeriabina / iStockphoto.com
A prenatal test sold by molecular diagnostics company Premaitha Health infringes patents owned by genetic sequencing firm Illumina, a UK court has ruled.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Illumina, Premaitha, English High Court, Ariosa Diagnostics, IONA test, patent infringement, Powell Gilbert, prenatal test
